Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients

Chronic kidney disease (CKD) is often associated with multiorgan complications, including thyroid hormone dysfunction. Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been proposed as a marker of inflammation that may contribute to these alterations. The main question it aims to answer is: Is there an association between interleukin-6 and thyroid hormone dysfunction in patients with chronic kidney disease (CKD) Blood samples will be collected and analyzed from 65 patients who have undergone hemodialysis for at least 3 months.

NCT Number	NCT07328113
Lead Sponsor	Dr. Soetomo General Hospital Collaborators: Universitas Airlangga Hospital, Surabaya
Conditions	Chronic Kidney Disease on Hemodialysis, Thyroid Gland Disease
Enrollment	65 participants
Start Date	2023-11-14
Primary Completion	2024-03-31 (estimated)
Study Completion	2024-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-08